Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Halfvarson

Showing results (91-100 of 244) with videos related to

Pageof 25
Sort By:
Eclinicalmedicine|December 5, 2022
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide studyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
Advances in Therapy|February 5, 2025
Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature ReviewPiotr Wiland, Charlotte Both, Norman B Gaylis, et al.
Scandinavian Journal of Gastroenterology|February 26, 2021
Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register - a validation studyGabriella Bröms, Jonas Söderling, Michael C Sachs, et al.
JAMA Pediatrics|August 20, 2019
Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide AttemptAgnieszka Butwicka, Ola Olén, Henrik Larsson, et al.
Advances in Therapy|April 28, 2025
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature ReviewPiotr Wiland, Charlotte Both, Norman B Gaylis, et al.
Eclinicalmedicine|September 4, 2023
Statin use and risk of colorectal cancer in patients with inflammatory bowel diseaseJiangwei Sun, Jonas Halfvarson, David Bergman, et al.
Gastroenterology|February 8, 2024
Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide StudyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
Journal of Crohn'S & Colitis|May 5, 2022
Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in SwedenSarita Shrestha, Judith S Brand, Jacob Järås, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2021
A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014Anders Forss, Mark Clements, David Bergman, et al.
Gut|April 26, 2018
No association between urbanisation, neighbourhood deprivation and IBD: a population-based study of 4 million individualsAgnieszka Butwicka, Amir Sariaslan, Henrik Larsson, et al.
Pageof 25

Showing results (91-100 of 244) with videos related to

Sort By:
Pageof 25
Eclinicalmedicine|December 5, 2022
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide studyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
Advances in Therapy|February 5, 2025
Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature ReviewPiotr Wiland, Charlotte Both, Norman B Gaylis, et al.
Scandinavian Journal of Gastroenterology|February 26, 2021
Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register - a validation studyGabriella Bröms, Jonas Söderling, Michael C Sachs, et al.
JAMA Pediatrics|August 20, 2019
Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide AttemptAgnieszka Butwicka, Ola Olén, Henrik Larsson, et al.
Advances in Therapy|April 28, 2025
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature ReviewPiotr Wiland, Charlotte Both, Norman B Gaylis, et al.
Eclinicalmedicine|September 4, 2023
Statin use and risk of colorectal cancer in patients with inflammatory bowel diseaseJiangwei Sun, Jonas Halfvarson, David Bergman, et al.
Gastroenterology|February 8, 2024
Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide StudyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
Journal of Crohn'S & Colitis|May 5, 2022
Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in SwedenSarita Shrestha, Judith S Brand, Jacob Järås, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2021
A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014Anders Forss, Mark Clements, David Bergman, et al.
Gut|April 26, 2018
No association between urbanisation, neighbourhood deprivation and IBD: a population-based study of 4 million individualsAgnieszka Butwicka, Amir Sariaslan, Henrik Larsson, et al.
Pageof 25